All three REVIVER devices have been listed on the Australian Register of Therapeutic Goods as a Class 1 Medical Device.
REVIVER is now demonstrating incredible results in improving balance and mobility in all types of patients with all types of neuromuscular diseases and conditions who have difficulty moving, balancing, and exercising. It allows people to exercise far beyond their unassisted capacity, including those who are so debilitated that they were no longer able to perform exercise.
It works by placing the user at a tilted angle and rotating them around. Placing the user at an angle has two consequences. Firstly, the vestibular system is strongly activated, to a degree not experienced in everyday life, or during other types of balance training. Secondly, muscles involved in the maintenance of balance reflexively contract to maintain an upright position.
The device has been under testing and development at a pilot clinic in Sydney, Australia. Outcomes at the pilot clinic have been extremely promising, with PD users experiencing a 22% (p<1x10-5; N=15, unpublished data) increase in mobility (reduction in timed up and go times; TUG) over an average period of 26 days.
Users also report improved balance, improved muscle tone, and capacity to return to desisted activities such as walking unassisted, climbing stairs and swimming. Numerous patients had lost the ability to walk unassisted, but regained this ability after 2-10 weeks of training on this machine.
Although other treatments may feature elements of the above benefits, no device to our knowledge has all the of these attributes in a single machine. Furthermore, given the tiled motion of the head in this treatment, it may also have an effect on glymphatic fluid and CSF flow in the brain.